Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
Flash
09:10
Investment bank DA Davidson raises Micron's target price to $2,000
According to Odaily, Citrini analyst jukan posted on X platform that a trading firm investment bank DA Davidson has raised Micron's target price to $2,000.
09:08
DA Davidson: Raises Micron's target price to $2000, maintains Buy rating
BlockBeats news, on June 25, American investment bank DA Davidson released a research report stating that Micron Technology has entered a new phase with some of the best performance visibility in the semiconductor industry, which marks a sharp contrast to its previous role in the semiconductor market. Driven by another quarter of results far exceeding expectations and positive forward guidance, the stock price surged. These signals indicate that the current boom cycle for memory chips is far from over. Although the company is increasing its capacity investment (capital expenditure for the fourth quarter of fiscal 2026 is expected to reach $10 billion), resulting in additional supply, management expects that the memory market will remain tight in terms of supply and demand at least until 2027. Based on this, DA Davidson reiterated its "buy" rating for Micron and raised its target price from $1,500 to $2,000, corresponding to a 20x price-earnings ratio for expected 2026 calendar year earnings per share (EPS).
09:08
US Stocks Movement | ARS Pharmaceuticals plummets 21% pre-market as it fails to secure new payer coverage and lowers full-year expense guidance
Golden Ten Data June 25|ARS Pharmaceuticals dropped 21.5% pre-market to $8.27. The main driver is that neffy failed to secure expanded commercial coverage in the July 1st insurance update cycle, combined with a downward revision of annual spending guidance. However, some analysts believe the market has overreacted — the coverage expansion is only delayed, cost discipline is strengthened, the 2027 breakeven target remains unchanged, and there is a potential CSU data catalyst in Q4.
News